BioCentury | Sep 7, 2018
Company News

Evotec, Celgene partner in targeted protein degredation deal

...Xetra:EVT) to identify difficult to track drug targets, focusing on targeted protein degradation, using Evotec’s Panomics...
...and royalties. Celgene will hold exclusive rights to all programs developed under the deal. Evotec’s Panomics...
BioCentury | Feb 18, 2013
Finance

Wanted: Platform plays

...which Biotie Therapies Corp. acquired in 2011 for €93.6 million ($120.8 million); microarray company Panomics Inc....
BioCentury | Aug 23, 2010
Tools & Techniques

Advanced in situ detection

...to founding ACD to develop the RNAscope technology, Luo was VP of functional genomics at Panomics Inc....
BioCentury | Jul 12, 2010
Finance

Suffering from Austerity

...of recent acquisitions and the realignment of sales territories. In 2008, Affymetrix made acquisitions including Panomics Inc....
BioCentury | Dec 15, 2008
Company News

Affymetrix, Panomics deal

...Affymetrix completed its previously announced acquisition of Panomics for $73 million in cash (see BioCentury, Nov...
...for $73 million in cash (see BioCentury, Nov. 17). Affymetrix Inc. (NASDAQ:AFFX), Santa Clara, Calif. Panomics Inc....
BioCentury | Dec 8, 2008
Analyst Picks & Changes

Analyst picks & changes

...Moreover, he said the company is still at a technological disadvantage despite acquiring microarray companies Panomics Inc....
BioCentury | Dec 8, 2008
Strategy

Affymetrix's self-diagnosis

...acquiring new technologies to expand into new markets. The microarray company's recent agreement to acquire Panomics Inc....
...drugs. Affymetrix hopes to expand into the low- to mid-plex genetic analysis space through the Panomics...
...analytes using technologies like PCR, mid-plex as 10-10,000 analytes, and high-plex as comprehensive, whole-genome coverage. Panomics...
BioCentury | Nov 17, 2008
Company News

Affymetrix, Panomics deal

...Affymetrix will acquire fellow microarray company Panomics for about $73 million in cash. Affymetrix gains Panomics'...
...to mid-multiplex assays for research use. Affymetrix plans to combine its whole genome microarrays with Panomics'...
...The deal is expected to close by year end. Affymetrix Inc. (NASDAQ:AFFX), Santa Clara, Calif. Panomics Inc....
BioCentury | Nov 17, 2008
Finance

Ebb & Flow

...week after the microarray company said it will acquire Panomics for $73 million in cash. Panomics...
BioCentury | Nov 12, 2008
Company News

Affymetrix to acquire Panomics

...Microarray company Affymetrix (NASDAQ:AFFX) will acquire Panomics (Fremont, Calif.) for $73 million in cash. Panomics markets...
Items per page:
1 - 10 of 32
BioCentury | Sep 7, 2018
Company News

Evotec, Celgene partner in targeted protein degredation deal

...Xetra:EVT) to identify difficult to track drug targets, focusing on targeted protein degradation, using Evotec’s Panomics...
...and royalties. Celgene will hold exclusive rights to all programs developed under the deal. Evotec’s Panomics...
BioCentury | Feb 18, 2013
Finance

Wanted: Platform plays

...which Biotie Therapies Corp. acquired in 2011 for €93.6 million ($120.8 million); microarray company Panomics Inc....
BioCentury | Aug 23, 2010
Tools & Techniques

Advanced in situ detection

...to founding ACD to develop the RNAscope technology, Luo was VP of functional genomics at Panomics Inc....
BioCentury | Jul 12, 2010
Finance

Suffering from Austerity

...of recent acquisitions and the realignment of sales territories. In 2008, Affymetrix made acquisitions including Panomics Inc....
BioCentury | Dec 15, 2008
Company News

Affymetrix, Panomics deal

...Affymetrix completed its previously announced acquisition of Panomics for $73 million in cash (see BioCentury, Nov...
...for $73 million in cash (see BioCentury, Nov. 17). Affymetrix Inc. (NASDAQ:AFFX), Santa Clara, Calif. Panomics Inc....
BioCentury | Dec 8, 2008
Analyst Picks & Changes

Analyst picks & changes

...Moreover, he said the company is still at a technological disadvantage despite acquiring microarray companies Panomics Inc....
BioCentury | Dec 8, 2008
Strategy

Affymetrix's self-diagnosis

...acquiring new technologies to expand into new markets. The microarray company's recent agreement to acquire Panomics Inc....
...drugs. Affymetrix hopes to expand into the low- to mid-plex genetic analysis space through the Panomics...
...analytes using technologies like PCR, mid-plex as 10-10,000 analytes, and high-plex as comprehensive, whole-genome coverage. Panomics...
BioCentury | Nov 17, 2008
Company News

Affymetrix, Panomics deal

...Affymetrix will acquire fellow microarray company Panomics for about $73 million in cash. Affymetrix gains Panomics'...
...to mid-multiplex assays for research use. Affymetrix plans to combine its whole genome microarrays with Panomics'...
...The deal is expected to close by year end. Affymetrix Inc. (NASDAQ:AFFX), Santa Clara, Calif. Panomics Inc....
BioCentury | Nov 17, 2008
Finance

Ebb & Flow

...week after the microarray company said it will acquire Panomics for $73 million in cash. Panomics...
BioCentury | Nov 12, 2008
Company News

Affymetrix to acquire Panomics

...Microarray company Affymetrix (NASDAQ:AFFX) will acquire Panomics (Fremont, Calif.) for $73 million in cash. Panomics markets...
Items per page:
1 - 10 of 32